- Home
- SLQT vs REPL Comparison
SLQT vs REPL Comparison
Compare SLQT & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- REPL
- Stock Information
- Founded
- SLQT 1999
- REPL 2015
- Country
- SLQT United States
- REPL United States
- Employees
- SLQT N/A
- REPL N/A
- Industry
- SLQT Specialty Insurers
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- REPL Health Care
- Exchange
- SLQT Nasdaq
- REPL Nasdaq
- Market Cap
- SLQT 682.6M
- REPL 780.3M
- IPO Year
- SLQT 2020
- REPL 2018
- Fundamental
- Price
- SLQT $4.25
- REPL $10.14
- Analyst Decision
- SLQT Hold
- REPL Strong Buy
- Analyst Count
- SLQT 1
- REPL 6
- Target Price
- SLQT $4.00
- REPL $17.50
- AVG Volume (30 Days)
- SLQT 1.3M
- REPL 794.9K
- Earning Date
- SLQT 02-05-2025
- REPL 02-06-2025
- Dividend Yield
- SLQT N/A
- REPL N/A
- EPS Growth
- SLQT N/A
- REPL N/A
- EPS
- SLQT N/A
- REPL N/A
- Revenue
- SLQT $1,381,309,000.00
- REPL N/A
- Revenue This Year
- SLQT $12.73
- REPL N/A
- Revenue Next Year
- SLQT $14.03
- REPL $300.41
- P/E Ratio
- SLQT N/A
- REPL N/A
- Revenue Growth
- SLQT 28.72
- REPL N/A
- 52 Week Low
- SLQT $1.03
- REPL $4.92
- 52 Week High
- SLQT $4.55
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- SLQT 67.89
- REPL 32.06
- Support Level
- SLQT $3.58
- REPL $10.00
- Resistance Level
- SLQT $4.39
- REPL $11.20
- Average True Range (ATR)
- SLQT 0.32
- REPL 0.84
- MACD
- SLQT -0.00
- REPL -0.20
- Stochastic Oscillator
- SLQT 71.96
- REPL 3.93
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.